Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 11:06 PM
Ignite Modification Date: 2025-12-25 @ 8:37 PM
NCT ID: NCT04447469
Term: Sputum culture positive
Organ System: Investigations
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA 23.0
Notes: None
Study: NCT04447469
Study Brief: Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 None 0 35 View
EG001 None 0 41 View
EG002 None 1 40 View
EG003 None 1 15 View
EG004 None 0 15 View
EG005 None 1 17 View
EG006 None 0 195 View
EG007 None 0 188 View
EG008 None 0 191 View
EG009 None 0 20 View
EG010 None 0 21 View
EG011 None 0 20 View